continue

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Source Node:
Time Stamp: October 24, 2023 11:54 AM - Modified On: October 24, 2023 - Published By:
Source Cluster:
Republished By Plato

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

Source Node:
Time Stamp: October 13, 2023 5:16 AM - Modified On: October 13, 2023 - Published By:
Source Cluster:
Republished By Plato

In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis in

K10 Esports Embarks on a Revolutionary Journey: From Championships to the TCG World Metaverse.

Source Node:
Time Stamp: October 6, 2023 12:01 PM - Modified On: October 6, 2023 - Published By:
Source Cluster:
Republished By Plato

An Exciting New Frontier for Esports Fans and Gamers Alike London, England. October 6, 2023. In a groundbreaking move that promises to redefine the esports landscape, the globally-renowned K10 Esports announces its next venture: diving into the world of the Metaverse with TCG World. As they continue their relentless pursuit of glory in games such as CS2, Valorant, and many more titles to come, K10 is now set to offer fans an unprecedented immersive experience by streaming their matches live in virtual venues within the TCG World Metaverse. This pioneering

Zumo first to launch platform built to meet the tech requirements of the FCA’s new Financial Promotions Regime for Crypto Assets

Source Node:
Time Stamp: October 6, 2023 7:12 AM - Modified On: October 6, 2023 - Published By:
Source Cluster:
Republished By Plato

  The award-winning platform has set a new benchmark in consumer protection and regulatory alignment With some UK operators having to pause activity, Zumo’s financial promotions technical flow is now also available through its B2B API to support unregistered firms with remaining compliant after the 8 October deadline [London/Edinburgh - Friday 29 September 2023] Zumo, the UK-based digital-asset-as-a-service platform, has announced a significant industry milestone as it becomes the first digital asset platform to have integrated tech based requirements of the Financial Conduct Authority’s (FCA’s) new financial promotions regime for

Do you know baccarat, the flower of online casino games?

Source Node:
Time Stamp: September 19, 2023 9:04 AM - Modified On: September 25, 2023 - Published By:
Source Cluster:
Republished By Plato

Baccarat is one of the most popular card games in casinos, and involves comparing cards between the player and the banker (or dealer) to determine the winner. The rules of Baccarat are simple, but it is a game that can be enjoyed in a variety of ways. Baccarat first appeared in online casino games in the mid-1900s when the Internet became popular. It was limited in the beginning, but in the 2000s, improvements in computer graphics and Internet speeds made it possible to provide a more realistic gaming environment, which

My Health Manifesto : Cracking The Code : Flying Solo

Source Node:
Time Stamp: September 11, 2023 12:37 PM - Modified On: September 11, 2023 - Published By:
Source Cluster:
Republished By Plato

Today when I Google "how long can a person live with my GFR 5% / kidney function the answer was "a few hours to a few weeks without dialysis." In a study with 8000+ patients 65+ with similar numbers; a month was the survival time. @68 (Stage 5 kidney failure is less than 15% /GFR; I'm not even anywhere on/near the chart) As I enter my Fourteenth/14th month; I am Defiantly hopeful. positive and optimistic that My Miracle will continue. #notmytimetodie #superoutlier While I challenge this death sentence I feel better and clearer

Welcome Renal Warriors

Source Node:
Time Stamp: September 11, 2023 7:58 AM - Modified On: September 11, 2023 - Published By:
Source Cluster:
Republished By Plato

I am a 68 year old man born in Brooklyn, New York and living for decades in Ithaca, NY. I also have 10 years each with homes in @San Ramon, Costa Rica and @Austin, Texas. My present and future dreams are in #Africa and I am setting up a base in @CapeTown, South Africa. #notmytimetodie #supportmymiracle #childofimmigrants #latebloomer. I was told a year ago that I would certainly die if I did not have not follow the standard treatment of care. I rejected both dialysis and a transplant and am

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Source Node:
Time Stamp: August 29, 2023 8:16 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Goverment Liason – Sandy

Source Node:
Time Stamp: August 9, 2023 5:37 AM - Modified On: August 9, 2023 - Published By:
Source Cluster:
Republished By Plato

Sandy Barsky Appointed as Government Liaison for the Blockchain & Infrastructure, the Rise of AI Conference. Washington, DC - [July 10, 2023] - The Government Blockchain Association (GBA) is thrilled to announce the appointment of Sandy Barsky as the Government Liaison for the upcoming Blockchain & Infrastructure, the Rise of AI Conference. The event is scheduled to take place on September 28-29, 2023, in Washington, DC. With an extensive background in the field, Sandy Barsky brings a wealth of experience to his new role. Having worked for decades at the

Government Blockchain Association (GBA) Deploys PlatoAi across GBA’s Opensource Intelligence Platform (OSINT)

Source Node:
Time Stamp: July 6, 2023 11:44 AM - Modified On: July 6, 2023 - Published By:
Source Cluster:
Republished By Plato

Washington DC, July 6th, 2023. Government Blockchain Association (GBA) announced the successful deployment of PlatoAi’s Ai Powered Web3 Intelligence inside the GBA Members Site. The result of this successful deployment stemmed from a strategic partnership between the two companies with a collective vision and deep commitment towards driving commercial adoption, standards and regulatory compliance of global government blockchain initiatives. Through this deployment GBA’s community will immediately benefit by accessing the latest premium intelligence across 36 Market Verticals including Ai, Digital Assets, Regulatory Initiatives, Web3, NFT’s, CyberSecurity, ESG and Carbon Offsets.

Crypto’s Moment of Truth

Source Node:
Time Stamp: July 1, 2023 9:26 AM - Modified On: July 1, 2023 - Published By:
Source Cluster:
Republished By Plato

In a pivotal moment for crypto, recent news that BlackRock and others such as Fidelity have filed for spot Bitcoin ETFs propelled BTC to a yearly high of just under $31,700. What does the arrival of these significant players mean for the future of crypto? For years, the prospect of a Bitcoin ETF approval in the United States has been shrouded in uncertainty. However, the tides are turning this time, as the involvement of industry giants like BlackRock hints at a higher likelihood of approval. Deniz, our CEO, echoes this